tirzepatide and prediabetes Is Mounjaro (tirzepatide) indicated for a patient with prediabetes, Hemoglobin A1C (HbA1c) of 6.2%, history of brain cancer, obesity? Tirzepatide yields sustained weight reduction

Semaglutide, an innovative GLP-1 agonist, activates adenylate cyclase and subsequently increases cyclic adenosine monophosphate (cAMP), which stimulates exchange protein (Epac), producing antiapoptotic and anti-inflammatory actions (Tamayo-Trujillo et al

Tirzepatide enhances insulin sensitivity and modifies glucagon secretion

Early intervention to prevent progression is also generally suboptimal

Talk with your healthcare provider to find out if you are at risk for angleclosure glaucoma and to get treatment to prevent it if you are at risk

Total losses vary widely based on baseline weight, genetics, diet adherence, and activity level, but clinical trials show approximately 15-22% total body weight loss over one year

After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on) to map your individual genetic pathways across 14 systems and 49 peptides, including key variants in the GLP1R and FTO genes that influence your response to semaglutide therapy